The value of in vitro studies in a case of neonatal diabetes with a novel Kir6.2-W68G mutation
Key Clinical Message: In infants, especially with novel previously undescribed mutations of the KATP channel causing neonatal diabetes, in vitro studies can be used to both predict the response to sulphonylurea treatment and support a second trial of glibenclamide at higher than standard doses if th...
Full description
Bibliographic Details
| Main Authors: |
O'Connell, S,
Proks, P,
Kramer, H,
Mattis, K,
Sachse, G,
Joyce, C,
Houghton, J,
Ellard, S,
Hattersley, A,
Ashcroft, F,
O'Riordan, S |
|---|
| Format: | Journal article
|
|---|
| Published: |
John Wiley and Sons Ltd
2015
|
|---|